These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 19208647)

  • 41. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
    Jain P; Nagaraja V
    Mol Microbiol; 2005 Dec; 58(5):1392-405. PubMed ID: 16313624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets.
    Das A; Dasgupta A; Sengupta T; Majumder HK
    Trends Parasitol; 2004 Aug; 20(8):381-7. PubMed ID: 15246322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Poisons of DNA topoisomerases I and II].
    Charcosset JY; Soues S; Laval F
    Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA topoisomerases in the unicellular protozoan parasites: Unwinding the mystery.
    Lamba S; Roy A
    Biochem Pharmacol; 2022 Sep; 203():115158. PubMed ID: 35780829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA topoisomerases as targets for anticancer drugs.
    Topcu Z
    J Clin Pharm Ther; 2001 Dec; 26(6):405-16. PubMed ID: 11722677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure and mechanism of DNA topoisomerases.
    Wigley DB
    Annu Rev Biophys Biomol Struct; 1995; 24():185-208. PubMed ID: 7663114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type II DNA topoisomerases in trypanosomatid and apicomplexan parasites.
    Chowdhury SR; Bhoumik A; Gupta VK; Majumder HK
    Acta Trop; 2022 Oct; 234():106613. PubMed ID: 35905776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Type IA topoisomerases can be "magicians" for both DNA and RNA in all domains of life.
    Ahmad M; Xu D; Wang W
    RNA Biol; 2017 Jul; 14(7):854-864. PubMed ID: 28534707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Escherichia coli DNA topoisomerase I mutant has a compensatory mutation that alters two residues between functional domains of the DNA gyrase A protein.
    Oram M; Fisher LM
    J Bacteriol; 1992 Jun; 174(12):4175-8. PubMed ID: 1317847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topoisomerase II, not topoisomerase I, is the proficient relaxase of nucleosomal DNA.
    Salceda J; Fernández X; Roca J
    EMBO J; 2006 Jun; 25(11):2575-83. PubMed ID: 16710299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The mechanisms of DNA topoisomerases.
    Roca J
    Trends Biochem Sci; 1995 Apr; 20(4):156-60. PubMed ID: 7770916
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The response of eukaryotic topoisomerases to DNA damage.
    Kingma PS; Osheroff N
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):223-32. PubMed ID: 9748592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure and mechanism of action of type IA DNA topoisomerases.
    Bugreev DV; Nevinsky GA
    Biochemistry (Mosc); 2009 Dec; 74(13):1467-81. PubMed ID: 20210704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. (-)-Menthol inhibits DNA topoisomerases I, II alpha and beta and promotes NF-kappaB expression in human gastric cancer SNU-5 cells.
    Lin JP; Lu HF; Lee JH; Lin JG; Hsia TC; Wu LT; Chung JG
    Anticancer Res; 2005; 25(3B):2069-74. PubMed ID: 16158947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The hydrophilic, protease-sensitive terminal domains of eucaryotic DNA topoisomerases have essential intracellular functions.
    Shaiu WL; Hu T; Hsieh TS
    Pac Symp Biocomput; 1999; ():578-89. PubMed ID: 10380229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA topoisomerases: essential enzymes and lethal targets.
    Chen AY; Liu LF
    Annu Rev Pharmacol Toxicol; 1994; 34():191-218. PubMed ID: 8042851
    [No Abstract]   [Full Text] [Related]  

  • 57. Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerases.
    Liu Q; Wang JC
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):881-6. PubMed ID: 9927662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The many lives of type IA topoisomerases.
    Bizard AH; Hickson ID
    J Biol Chem; 2020 May; 295(20):7138-7153. PubMed ID: 32277049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases.
    Corbett KD; Berger JM
    Annu Rev Biophys Biomol Struct; 2004; 33():95-118. PubMed ID: 15139806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The origin of viruses and their possible roles in major evolutionary transitions.
    Forterre P
    Virus Res; 2006 Apr; 117(1):5-16. PubMed ID: 16476498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.